Pursuant to Regulation 30 read with Clause 3 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suraksha Diagnostic has informed that Crisil Ratings (‘Crisil’), has migrated the rating on the long-term bank facilities of the Company from 'Crisil B (Issuer Not Cooperating) / Stable' to ‘Crisil A- / Stable’ and has assigned its ‘Crisil A2+’ rating on the short-term bank facilities of the Company on 08 October 2025. The rating rationale has been uploaded on Crisil’s website and please note that this information shall also be made available at the Company’s website at www.surakshanet.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7515.25 |
| Max Healthcare Inst | 951.20 |
| Narayana Hrudayalay | 1769.10 |
| Aster DM Healthcare | 665.85 |
| Global Health | 1060.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: